首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke
【2h】

Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke

机译:间充质基质细胞中的细胞外囊泡:一种新的中风治疗策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A stroke is a focal cerebral insult that frequently causes severe neurological deficit and mortality. Recent studies have demonstrated that multipotent mesenchymal stromal cells (MSCs) hold great promise for neurovascular remodeling and neurological function recovery following a stroke. Rather than a direct replacement of parenchymal brain cells, the therapeutic mechanism of MSCs is suggested to be the secretion of soluble factors. Specifically, emerging data described MSCs as being able to release extracellular vesicles (EVs), which contain a variety of cargo including proteins, lipids, DNA and various RNA species. The released EVs can target neurocytes and vascular cells and modify the cell's functions by delivering the cargo, which are considered to mediate the neural restoration effects of MSCs. Therefore, EVs may be developed as a novel cell-free therapy for neurological disorders. In the present review, the current advances regarding the components, functions and therapeutic potential of EVs are summarized and the use of MSC-derived EVs as a promising approach in the treatment of stroke are highlighted.
机译:中风是一种局灶性脑损伤,经常导致严重的神经功能缺损和死亡。最近的研究表明,多能间质基质细胞(MSCs)对于中风后神经血管重塑和神经功能恢复具有广阔的前景。 MSCs的治疗机制不是直接替代实质脑细胞,而是可溶性因子的分泌。具体而言,新出现的数据描述了MSC具有释放细胞外囊泡(EVs)的能力,其中包含蛋白质,脂质,DNA和各种RNA种类的多种货物。释放的电动汽车可以靶向神经细胞和血管细胞,并通过运送货物来改变细胞的功能,这被认为可以介导MSC的神经修复作用。因此,电动汽车可能会发展为一种新型的无细胞疗法治疗神经系统疾病。在本综述中,总结了有关电动汽车的组成,功能和治疗潜力的最新进展,并着重介绍了将MSC衍生电动汽车作为治疗中风的一种有前途的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号